Tags

Type your tag names separated by a space and hit enter

Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy.
Acta Radiol. 2016 Oct; 57(10):1205-9.AR

Abstract

BACKGROUND

As a minimally invasive treatment, ethanol sclerotherapy has been used for large symptomatic hepatic cysts, but there are not many long-term reports on treatment outcomes and safety.

PURPOSE

To evaluate the long-term outcomes of percutaneous ethanol sclerotherapy in patients with large symptomatic hepatic cysts.

MATERIAL AND METHODS

This study included 43 symptomatic, enlarging hepatic cysts in 42 patients who had undergone ethanol sclerotherapy from 2003 to 2013 and were followed up for >1 year. The treatment outcomes were evaluated in terms of the reduction of cyst size and resolution of symptoms. The patients were followed up for a mean period of 33 months with either ultrasound or computed tomography examination.

RESULTS

Thirty-nine hepatic cysts (91%) were successfully treated with ethanol sclerotherapy, showing resolution of symptoms and remarkable reduction in cyst volume. Eight hepatic cysts (19%) disappeared completely, and 31 hepatic cysts (72%) decreased in size during the follow-up period. The mean diameter of the cysts decreased from 12.5 ± 4.4 cm to 3.8 ± 3.4 cm during follow-up. There were no immediate serious complications related to the procedure. There were four cases (9%) of treatment failure requiring subsequent surgical procedures.

CONCLUSION

Percutaneous ethanol sclerotherapy can be considered as an effective first-line treatment for large symptomatic hepatic cysts.

Authors+Show Affiliations

Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea psyoung0419@gmail.com.Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.Department of Radiology, Kyungpook National University School of Medicine, Daegu, Republic of Korea.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26787678

Citation

Jang, Se Young, et al. "Long-term Follow-up of Large Symptomatic Hepatic Cysts Treated By Percutaneous Ethanol Sclerotherapy." Acta Radiologica (Stockholm, Sweden : 1987), vol. 57, no. 10, 2016, pp. 1205-9.
Jang SY, Park SY, Tak WY, et al. Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. Acta Radiol. 2016;57(10):1205-9.
Jang, S. Y., Park, S. Y., Tak, W. Y., Kweon, Y. O., & Ryeom, H. (2016). Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. Acta Radiologica (Stockholm, Sweden : 1987), 57(10), 1205-9. https://doi.org/10.1177/0284185115626476
Jang SY, et al. Long-term Follow-up of Large Symptomatic Hepatic Cysts Treated By Percutaneous Ethanol Sclerotherapy. Acta Radiol. 2016;57(10):1205-9. PubMed PMID: 26787678.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. AU - Jang,Se Young, AU - Park,Soo Young, AU - Tak,Won Young, AU - Kweon,Young Oh, AU - Ryeom,Hunkyu, Y1 - 2016/01/18/ PY - 2015/07/18/received PY - 2015/11/23/accepted PY - 2016/1/21/entrez PY - 2016/1/21/pubmed PY - 2017/1/28/medline KW - Hepatic cyst KW - ethanol KW - multiple sessions KW - percutaneous KW - sclerotherapy KW - single prolonged session SP - 1205 EP - 9 JF - Acta radiologica (Stockholm, Sweden : 1987) JO - Acta Radiol VL - 57 IS - 10 N2 - BACKGROUND: As a minimally invasive treatment, ethanol sclerotherapy has been used for large symptomatic hepatic cysts, but there are not many long-term reports on treatment outcomes and safety. PURPOSE: To evaluate the long-term outcomes of percutaneous ethanol sclerotherapy in patients with large symptomatic hepatic cysts. MATERIAL AND METHODS: This study included 43 symptomatic, enlarging hepatic cysts in 42 patients who had undergone ethanol sclerotherapy from 2003 to 2013 and were followed up for >1 year. The treatment outcomes were evaluated in terms of the reduction of cyst size and resolution of symptoms. The patients were followed up for a mean period of 33 months with either ultrasound or computed tomography examination. RESULTS: Thirty-nine hepatic cysts (91%) were successfully treated with ethanol sclerotherapy, showing resolution of symptoms and remarkable reduction in cyst volume. Eight hepatic cysts (19%) disappeared completely, and 31 hepatic cysts (72%) decreased in size during the follow-up period. The mean diameter of the cysts decreased from 12.5 ± 4.4 cm to 3.8 ± 3.4 cm during follow-up. There were no immediate serious complications related to the procedure. There were four cases (9%) of treatment failure requiring subsequent surgical procedures. CONCLUSION: Percutaneous ethanol sclerotherapy can be considered as an effective first-line treatment for large symptomatic hepatic cysts. SN - 1600-0455 UR - https://www.unboundmedicine.com/medline/citation/26787678/Long_term_follow_up_of_large_symptomatic_hepatic_cysts_treated_by_percutaneous_ethanol_sclerotherapy_ L2 - https://journals.sagepub.com/doi/10.1177/0284185115626476?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -